Morgan Stanley’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $915K | Buy |
|
|||||
|
2024
Q1 | $757K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | $50.6K | Sell |
|
|||||
|
2023
Q2 | $367K | Sell |
|
|||||
|
2023
Q1 | $705K | Sell |
|
|||||
|
2022
Q4 | $2.01M | Buy |
|
|||||
|
2022
Q3 | $4.22M | Buy |
|
|||||
|
2022
Q2 | $903K | Sell |
|
|||||
|
2022
Q1 | $2.09M | Sell |
|
|||||
|
2021
Q4 | $3.69M | Buy |
|
|||||
|
2021
Q3 | $4.65M | Sell |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $5.69M | Buy |
|
|||||
|
2020
Q4 | $4.21M | Buy |
|
|||||
|
2020
Q3 | $1.62M | Buy |
|
|||||
|
2020
Q2 | $1.04M | Sell |
|
|||||
|
2020
Q1 | $1.68M | Buy |
|
|||||
|
2019
Q4 | $1.84M | Sell |
|
|||||
|
2019
Q3 | $3.67M | Buy |
|
|||||
|
2019
Q2 | $430K | Sell |
|
|||||
|
2019
Q1 | $5.91M | Buy |
|
|||||
|
2018
Q4 | $3.95M | Buy |
|
|||||
|
2018
Q3 | $1.92M | Sell |
|
|||||
|
2018
Q2 | $1.91M | Buy |
|
|||||
|
2018
Q1 | $1.14M | Buy |
|
|||||
|
2017
Q4 | $319K | Buy |
|
|||||
|
2017
Q3 | $250K | Buy |
|
|||||
|
2017
Q2 | $32K | Buy |
|